Cargando…
RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity
Autores principales: | Hu, Xiao, Moisan, Jacques, Majchrzak, Kinga, Lesch, Chuck, Wang, Yahong, Sanchez, Brian, Liu, Xikui, Morgan, Rodney, Mertz, David, Bousley, Dick, van Huis, Chad, Skalitzky, Don, Taylor, Clarke, Aicher, Thomas, Toogood, Peter, Zou, Weiping, Glick, Gary, Paulos, Chrystal, Carter, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645271/ http://dx.doi.org/10.1186/2051-1426-3-S2-P23 |
Ejemplares similares
-
Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity
por: Hu, Xiao, et al.
Publicado: (2016) -
Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
por: Hu, Xiao, et al.
Publicado: (2014) -
Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand
por: Marcotte, Douglas J., et al.
Publicado: (2016) -
Effective Activation and Expansion of Canine Lymphocytes Using a Novel Nano-Sized Magnetic Beads Approach
por: Szopa, Iwona Monika, et al.
Publicado: (2021) -
The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies
por: Neal, Lillian R., et al.
Publicado: (2017)